To evaluate the in vivo effect of MAP7D1 on tumor growth and metastasis, we established an orthotopic breast cancer mouse model (Figure S10A) using MCF7 cells overexpressing MAP7D1 or MDA-MB-231 cells with MAP7D1 knockdown (Figures S8F and S9C). Here, MAP7D1 is linked to breast cancer.